instruction
stringlengths
33
156
input
float64
output
stringlengths
120
1.97k
Does Abatacept and Methotrimeprazine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Methotrimeprazine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Methoxyflurane interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Methoxyflurane can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Methsuximide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Methsuximide can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Methylene blue interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Methylene blue can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Methylprednisolone interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Methyltestosterone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Methyltestosterone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Metoclopramide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Metoclopramide can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Metoprolol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Metoprolol can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Metronidazole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Metronidazole can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Mexiletine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Mexiletine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Mianserin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Mianserin can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Midazolam interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Midazolam can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Midostaurin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Midostaurin can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Mifepristone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Mifepristone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Mirabegron interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Mirabegron can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Mirtazapine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Mirtazapine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Mitomycin interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Mitomycin is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Mitoxantrone interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Mobocertinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Mobocertinib can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Moclobemide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Moclobemide can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Modafinil interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Modafinil can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Moderna COVID-19 Vaccine interact?
null
Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Modified vaccinia ankara interact?
null
Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Mometasone furoate interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Mometasone furoate, and the severity of the interaction is major.
Does Abatacept and Monomethyl fumarate interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Monomethyl fumarate, and the severity of the interaction is major.
Does Abatacept and Montelukast interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Montelukast can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Morphine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Morphine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Mosunetuzumab interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Mosunetuzumab, and the severity of the interaction is major.
Does Abatacept and Nefazodone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Nefazodone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Nelarabine interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Nelarabine is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Nelfinavir interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Nelfinavir can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Neratinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Neratinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Nevirapine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Nevirapine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Nicardipine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Nicardipine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Nicergoline interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Nicergoline can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Niclosamide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Niclosamide can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Nicotine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Nicotine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Olanzapine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Olanzapine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Olaparib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Olaparib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Oliceridine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Oliceridine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Olodaterol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Olodaterol can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Omeprazole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Omeprazole can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Ondansetron interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Ondansetron can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Opium interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Opium can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Osilodrostat interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Osilodrostat can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Osimertinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Osimertinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Ospemifene interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Ospemifene can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Oxaliplatin interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Oxtriphylline interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Oxtriphylline can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Oxybutynin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Oxybutynin can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Oxycodone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Oxycodone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Oxymorphone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Oxymorphone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Ozanimod interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Ozanimod, and the severity of the interaction is major.
Does Abatacept and Paclitaxel interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates with a narrow therapeutic index. In short, The metabolism of Paclitaxel can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Palbociclib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Palbociclib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Paliperidone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Paliperidone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Palonosetron interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Palonosetron can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Panobinostat interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Panobinostat can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Pantoprazole interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Pantoprazole can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Parecoxib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Parecoxib can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Paroxetine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Paroxetine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pazopanib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates with a narrow therapeutic index. In short, The metabolism of Pazopanib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Pegaspargase interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Pegcetacoplan interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Pegcetacoplan, and the severity of the interaction is major.
Does Abatacept and Peginterferon alfa-2a interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Peginterferon alfa-2b interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Peginterferon beta-1a interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Peginterferon beta-1a, and the severity of the interaction is major.
Does Abatacept and Pemetrexed interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Pemetrexed can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Penbutolol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Penbutolol can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Penciclovir interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Penciclovir can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Penicillamine interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Penicillamine is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Pentamidine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Pentamidine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pentobarbital interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Pentobarbital can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pentostatin interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Pentostatin is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Pentoxifylline interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Pentoxifylline can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Perampanel interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Perampanel can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Perphenazine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Perphenazine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pexidartinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Pexidartinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Phenobarbital interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates with a narrow therapeutic index. In short, The metabolism of Phenobarbital can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Phenprocoumon interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates with a narrow therapeutic index. In short, The metabolism of Phenprocoumon can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Phenylalanine interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Phenylalanine is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Phenytoin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates with a narrow therapeutic index. In short, The metabolism of Phenytoin can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Pimavanserin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates. In short, The metabolism of Pimavanserin can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pimecrolimus interact?
null
While a causal relationship is not established, there are concerns in the literature about a potential long-term risk of skin cancer and lymphoma 1 with the use of topical calcineurin inhibitors, including pimecrolimus, based on previous information and the drug mechanism of action. A very small number of people who have used pimecrolimus cream, 1% have developed cancer (for example, skin cancer or lymphoma). The concurrent administration of pimecrolimus may be associated with an increased level of immunosuppression in immunocompromised patients, including those who are on systemic immunosuppressive medications. Resulting complications may include an increased risk of infection, lymphoma, and skin malignancies. In short, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Pimozide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Pimozide can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Pindolol interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Pindolol can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pioglitazone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Pioglitazone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Piperazine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Piperazine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pipotiazine interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Pipotiazine can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pirfenidone interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Pirfenidone can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Piroxicam interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Piroxicam can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pirtobrutinib interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Pirtobrutinib, and the severity of the interaction is major.
Does Abatacept and Pitavastatin interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Pitavastatin can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pitolisant interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Pitolisant can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pomalidomide interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates with a narrow therapeutic index. In short, The metabolism of Pomalidomide can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Ponatinib interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates with a narrow therapeutic index. In short, The metabolism of Ponatinib can be increased when combined with Abatacept, and the severity of the interaction is major.
Does Abatacept and Ponesimod interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Ponesimod can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Pralatrexate interact?
null
Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Abatacept is combined with Pralatrexate, and the severity of the interaction is major.
Does Abatacept and Prasugrel interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Prasugrel can be increased when combined with Abatacept, and the severity of the interaction is moderate.
Does Abatacept and Praziquantel interact?
null
The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Praziquantel can be increased when combined with Abatacept, and the severity of the interaction is moderate.